| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |